Jeff Friedman

Jeff Friedman is the current director at DTx Pharma. Jeff has also previously been a member of the board of directors at MatriSys Bioscience, Inc. and Celsense, Inc. Jeff has a background in technology and has been instrumental in the success of many startups. Jeff is passionate about helping others and making a difference in the world.

Jeff Friedman attended the Massachusetts Institute of Technology, where they earned a Bachelor of Science in Biology/Biological Sciences, General. Jeff then attended Stanford University School of Medicine, where they earned a Doctor of Medicine (MD). Jeff completed an internship/residency at the Pediatrics Residency Program at Boston Children's Hospital and then a fellowship at Dana Farber Cancer Institute in Pediatric Hematology-Oncology Research. Jeff also earned a Doctor of Philosophy (Ph.D.) in Cancer Biology from Stanford University. Jeff is certified by The Medical Board of California in California Medical License.